Last reviewed · How we verify
NCT07205692: MCaRT
Multimorbidity and Cardiovascular Risk Factors After Renal Transplant
trial in Kidney Transplant in 30 participants. Currently enrolling.
1 August 2027
Quick facts
| Lead sponsor | University Hospitals of Derby and Burton NHS Foundation Trust |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30 |
| Start date | 5 September 2025 |
| Primary completion | 1 August 2027 |
| Estimated completion | 1 August 2027 |
| Sites | 1 location across United Kingdom |
Conditions studied
- Kidney Transplant — all drugs for Kidney Transplant →
- Cardiovascular (CV) Risk — all drugs for Cardiovascular (CV) Risk →
- Multimorbidity — all drugs for Multimorbidity →
Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Who can join
18 and older, any sex, with Kidney Transplant or Cardiovascular (CV) Risk. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Who can participate? Any adults over the age of 18 who have received a kidney transplant at the research centre are eligible for recruitment within the first month after transplant What does the study involve? The study involves observing and gathering data to understand how the health of people who receive a kidney transplant changes over the first year. In particular the investigators are interested in the risk factors for heart disease and stroke, and how these change over the first year of transplant. The investigators are also interested in multiple health conditions, and how these impact patients after transplant. There are no interventions but there will be measurements of diagnoses, risk factors for heart disease and stroke, and assessments of physical fitness Blood pressure, BMI, routine blood tests as well as assessing muscle and fat changes, how fit patients are and what new health conditions they have. What are the possible benefits and risks of participating? There is no active treatment or intervention, so there are no risks of benefits compared to normal care. Where is the study run from? University Hospitals of Derby and Burton NHS trust, at the Royal Derby hospital Renal Department. When is the study starting and how long is it expected to run for? The study is expected to start 1/9/2025 and run for 2 years. Who is funding the study? The only costs of the study are funding for the staff member running the study, who is funded by the NIHR as an academic research fellow Who is the main contact? Dr Samuel Strain, Samuel.strain@nottingham.ac.uk
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07205692
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Kidney Transplant
Currently open trials in the same condition.
- NCT07532382 — Personalized Stories for Pediatric Kidney Recipients · recruiting
- NCT07348458 — Kidney Protective Jacket · NA · recruiting
- NCT07333495 — A Mixed Cohort, Multicentre Exploratory Study of Non-invasive Quantitative Assessment of Renal Graft Function With Non-c · recruiting
- NCT06919003 — Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE · Phase 2 · recruiting
- NCT06833463 — Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients · recruiting
Other University Hospitals of Derby and Burton NHS Foundation Trust trials
Trials by the same sponsor.
- NCT07377500 — Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis · NA · not yet recruiting
- NCT06109662 — Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease · active not recruiting
- NCT06259305 — Memories in Heartbeats Study · NA · completed
- NCT06284044 — Facilitating Safe Transition to Home for Preterm Infants - a National Database Study · completed
- NCT06164015 — 3D Ultrasound to Assess in Recurrent Miscarriage · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07205692 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospitals of Derby and Burton NHS Foundation Trust
- Last refreshed: 3 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07205692.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing